|Head and Neck Cancer||62||South Africa||2015||currently in treatment|
Daniel, Head and Neck Cancer
|62||South Africa||2015||currently in treatment|
62-year old male affected by an unknown head & neck primary site tumor poorly differentiated into squamous cell carcinoma.
Diagnostic: Squamous Cell Carcinoma with bilateral metastases in neck and axillary nodes
Biomarkers already tested:
– Cetuximab (Erbitux)
OncoDNA observed a high expression of PD-L1 which is associated with a good prognosis for such therapy.
– FGFR3 variant
– IHC: high expression of PD-L1
– Anti-PD-L1 (Nivolumab since Oct 2015)
The patient is treated with nivolumab and shows a good response with 6 months of OS for the moment.
Dr Ettienne MYBURGH
The value of OncoDEEP comes into play when patients have failed first line therapy or patients have had progression of disease.